Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: milestone / Re: For those of you who ascribe to the argument of knowing/not

Part secured, part unsecured, which begs the question on what grounds? How was PTSC persuaded to lend approximately half the total on an unsecured basis?

Productive licensing had slowed because of the ongoing re-examination requests, and it is difficult to argue that the main cause was the PTSC/TPL dispute. As a consequence of the NIRC and Sirius settlement, has the relationship between the two improved?

Was the delay in receiving the second NIRC the reason TPL defaulted on the loans. Was the Sirius settlement conditional on the NIRC? Was the USPTO long overdue on the '336 decision, thereby having a knock-on effect on other obligations?

Without knowing why actions were taken it is so easy to focus only on the negative and suggesting a lack of ability on the part of those making the decisions.

.

.

.

Be well

Share
New Message
Please login to post a reply